February 16, 2016
On Tuesday, February 16, SNMMI submitted comments to the U.S. Nuclear Regulatory Commission (NRC) on a number of issues associated with medical treatment of patients with sodium iodide I–131. As previously reported, NRC released a Federal Register Notice in November 2015, seeking information about patient concerns about medical treatment involving the use of I–131, information that physicians use to make decisions on when it is safe to release I–131 patients based on radiation exposure concerns, radiation safety information used by I–131 patients after their release, and the availability of a radiation safety informational guidance brochure for I–131 patients that can be distributed nationwide.
The society shared the SNMMI patient brochure as well as feedback received from members regarding specific release recommendations.
The information NRC collects will be used to develop a Web site to provide patients with clear and consistent information about radioactive iodine treatments and to revise NRC patient release guidance.